



Q-VD-OPH, Z-VD-OPH, Boc-D-OPH, Z-DEVD-OPH, Z-VAD(OMe)-FMK, Z-VAD-FMK( non methylated) Boc-D-
FMK,Z-DEVD-FMK, Z-IETD-FMK, Z-LEHD-FMK, Z-VEID-FMK, Z-AEVD-FMK, Z-VDVAD-FMK, Z-LEVD-FMK,Z-
ATAD-FMK, Biotin-VAD-FMK, Biotin-DEVD-FMK, Z-FA-FMK, Biotin-FA-FMK, Z-FF-FMK, Z-LLY-FMK, Z-VAM-
FMK, FITC-VAD-FMK, FAM-VAD-FMK, FAM-DEVD-FMK, SR-VAD-FMK, SR-DEVD-FMK, CASPASE /
APOPTOSIS INHIBITORS AND DETECTION KITS CATHEPSIN, CALPAIN INHIBITORS, PEPTIDE ALDEHYDE
INHIBITORS, FLUOROGENIC (AMC, AFC), GLY-PHE-DIAZOMETHYLKETONE, CHROMOGENIC ( PNA )
SUBSTRATES.
SM Biochemicals offers a wide variety of peptides including Adrenocorticotropic Hormone(ACTH),
Adrenomedullins, ADAM Substrate, Agatoxin IVa, Akt Substrate, All D Beta Amyloid, Alpha MSH, Amylin,
Amyloid, Angiotensin, APP, a great number of Beta Amyloids which have been found to offer useful
tools in Alzheimer's research.Bradykinin, Calcitonin,Casein Kinase, Cecropin B,Cecropin P1,porcine,
Corticotropin,Endothelins, Endothelin Antagonists, Exendin 3,Enzyme Inhibitors, Fibrinogen Binding,
Fibrinopeptide, Flag Peptide, Furin InhibitorII,Galanin,Galantide, Gamma Secretase Inhibitor, Gastric
Inhibitory Peptide, human / GIP, human, Gastrin, Gastrin Releasing Peptide, human / GRP, Ghrelin,
Glucagon, Growth Hormone Releasing Factor, H.I.V. -1 Protease, Hepatitis C Virus, HIV Substrate IV, HIV
Substrate IV Inhibitor I, Humanin, KISS, Leumorphin, LH-RH Free Acid, Locustapyrokinin. MG-132/
Proteosome inhibitor, MMP Substrates and Inhibitors, MOG Protein, Motlin Peptides, Myosin, MZ
Peptides, Neuropeptide, Neurotensin, NFF2 MMP subsrates, Non A Beta component Amyloid, Obestatin,
Oxerin A and Oxerin B ( Human), Orntide, Oxyntomodulin, PACAP, Pancreastatin, Pancreatic
polypeptide, Parathyroid Hormone, PKA Inhibitor and Substrate, Plasminogen activator substrate,
Protein Kinase, PTH Peptide/Protein, PYY Peptide/Protein, Sarafotoxin peptides, Somatostatin peptides,
Syntide, TNF converting enzyme substrate, Tyrosine specific protein kinase, Vasoactive intestinal
constrictor, VIP peptides, VIP Antagonist, VIP Receptor, Xenopsin.
We provide peptides for both research and bulk pharmeceutical trials. A staff with decades of
experience in peptide chemistry will help you with the design and synthesis of your custom peptides
and with the technical information necessary to help you optimize your research results.
Active Pharmaceutical Ingredients ( APIs and Intermediates). Pharmaceutically active peptides.
Call our number (714)993-9461 or (925)876-3111 or email at info@smbiochemicals.com
Catalog #
|
Peptide Name
|
|
|
|
SM231-40
|
Parathyroid Hormone (1-34), human / PTH (1-34), human
|
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Le u-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val- Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-H is-Asn-Phe-OH
|
|
|
SM231-40
|
Parathyroid Hormone (1-34), human / PTH (1-34), human
|
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Le u-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val- Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-H is-Asn-Phe-OH
|
|
|
SM231-50
|
Parathyroid Hormone (39-68), human / PTH (39-68), h
|
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gl n-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu -Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-OH
|
|
|
SM231-50
|
Parathyroid Hormone (39-68), human / PTH (39-68), h
|
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gl n-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu -Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-OH
|
|
|
SM231-55
|
Parathyroid Hormone (39-84), human / PTH (39-84), h
|
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gl n-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu -Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Al a-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys- Ala-Lys-Ser-Gln-OH
|
|
|
SM231-55
|
Parathyroid Hormone (39-84), human / PTH (39-84), h
|
Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gl n-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu -Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Al a-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys- Ala-Lys-Ser-Gln-OH
|
|
|
SM231-60
|
Parathyroid Hormone (53-84), human / PTH (53-84), h
|
Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-H is-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala- Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gl n-OH
|
|
|
SM231-60
|
Parathyroid Hormone (53-84), human / PTH (53-84), h
|
Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-H is-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala- Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gl n-OH
|
|
|
SM867-10
|
PKA Inhibitor
|
Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr- Gly-Arg-Arg-Asn-Ala-Ile-NH2
|
|
|
SM867-10
|
PKA Inhibitor
|
Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr- Gly-Arg-Arg-Asn-Ala-Ile-NH2
|
|
|
SM866-25
|
PKA Substrate
|
Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ser-Ile-NH2
|
|
|
SM866-25
|
PKA Substrate
|
Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ser-Ile-NH2
|
|
|
SM875-17
|
Plasminogen Activator Substrate
|
BOC-Val-Gly-Arg-beta-napthyl-amide
|
|
|
SM893-15
|
Prostate Specific Antigen Substrate
|
Morpholinecarbonyl-His-Ser-Ser-Lys-Leu-Gl n-7-amino-4(Trifluoromethyl)-coumaride
|
|
|
SM891-15
|
Prostate Specific Antigen Substrate
|
4-Morpholinecarbonyl-His-Ser-Ser-Lys-Leu- Gln-Amino-methylcoumaride
|
|
|
SM890-91
|
Prot. Kin. C Pseudosubstrate Inhibitor
|
Myristoyl-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg- Trp-Arg-Lys-Leu-OH
|
|
|
SM890-82
|
Protein Kinase C Substrate
|
Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH
|
|
|
SM871-55
|
Protein Kinase C Substrate from EGF Receptor
|
Lys-Arg-Thr-Leu-Arg-Arg-OH
|
|
|
SM871-55
|
Protein Kinase C Substrate from EGF Receptor
|
Lys-Arg-Thr-Leu-Arg-Arg-OH
|
|
|
SM871-87
|
Protein Kinase Inhibitor Cdk2
|
Tyr-Ser-Phe-Val-His-His-Gly-Phe-Phe-Asn-P he-Arg-Val-Ser-Trp-Arg-Glu-Met-Leu-Ala-OH
|
|
|
SM871-87
|
Protein Kinase Inhibitor Cdk2
|
Tyr-Ser-Phe-Val-His-His-Gly-Phe-Phe-Asn-P he-Arg-Val-Ser-Trp-Arg-Glu-Met-Leu-Ala-OH
|
|
|
SM231-43
|
PTH (2-34), human
|
Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gl y-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu- Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-A sn-Phe-OH
|
|
|
SM231-43
|
PTH (2-34), human
|
Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gl y-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu- Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-A sn-Phe-OH
|
|
|
SM231-46
|
PTH (3-34), human
|
Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Ly s-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp- Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn- Phe-OH
|
|
|
SM231-46
|
PTH (3-34), human
|
Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Ly s-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp- Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn- Phe-OH
|
|
|
SM231-48
|
PTH (4-34), human
|
Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-Hi s-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu -Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe- OH
|
|
|
SM231-48
|
PTH (4-34), human
|
Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-Hi s-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu -Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe- OH
|
|
|
SM231-51
|
PTH (5-34), human
|
Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Le u-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg- Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM231-51
|
PTH (5-34), human
|
Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Le u-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg- Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
|
|
|
SM233-35
|
PTH [Nle8,18,Tyr34] (3-34), amide, bovine Parathyroid Hormone
|
Ser-Glu-Ile-Gln-Phe-050-His-Asn-Leu-Gly-L ys-His-Leu-Ser-Ser-NorLeu-Glu-Arg-Val-Glu -Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His- Asn-Tyr-NH2
|
|
|
SM233-35
|
PTH [Nle8,18,Tyr34] (3-34), amide, bovine Parathyroid Hormone
|
Ser-Glu-Ile-Gln-Phe-050-His-Asn-Leu-Gly-L ys-His-Leu-Ser-Ser-NorLeu-Glu-Arg-Val-Glu -Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His- Asn-Tyr-NH2
|
|
|
SM231-85
|
PTH Related protein (1-40) Hypercalcemia Malignancy Factor
|
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-L ys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg- Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-Hi s-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser-OH
|
|
|
SM231-85
|
PTH Related protein (1-40) Hypercalcemia Malignancy Factor
|
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-L ys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg- Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-Hi s-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser-OH
|
|
|
SM490-56
|
PYY (3-36), porcine
|
Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Se r-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-L eu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln -Arg-Tyr-NH2
|
|
|
SM490-56
|
PYY (3-36), porcine
|
Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Se r-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-L eu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln -Arg-Tyr-NH2
|
|
|
SM490-11
|
PYY / Peptide YY (3-36), human
|
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser -Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-L eu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln -Arg-Tyr-NH2
|
|
|
SM490-11
|
PYY / Peptide YY (3-36), human
|
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser -Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-L eu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln -Arg-Tyr-NH2
|
|
|
|